ITP
DMTK

Iron Triangle Partners’s DermTech, Inc. Common Stock DMTK Stock Holding History

Iron Triangle Partners’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-250,000
Closed -$10.4M – 33
2021
Q2 		$10.4M Hold
250,000
– – 1.07% 23
2021
Q1 		$12.7M Buy
+250,000
New +$13.1M 1.61% 23

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

Iron Triangle Partners's DMTK Position: Q3 2021 in Review

Iron Triangle Partners sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2021, closing a stake of 250,000 shares — an estimated $10.4M sold.

Iron Triangle Partners first reported a position in DMTK in Q1 2021 and held it in 2 quarters. The position peaked at $12.7M in Q1 2021. 162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

  • Iron Triangle Partners reported no remaining DermTech, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Iron Triangle Partners sold 250,000 DermTech, Inc. Common Stock shares in Q3 2021, an estimated $10.4M.
  • Iron Triangle Partners first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Iron Triangle Partners's DermTech, Inc. Common Stock position peaked at $12.7M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Iron Triangle Partners's 13F filing for Q3 2021, filed 15 Nov 2021.